Premium
Selecting haematological malignancy patients for intravenous immunoglobulin
Author(s) -
Paxton L.,
Hawkins C.,
Crispin P.
Publication year - 2016
Publication title -
internal medicine journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.596
H-Index - 70
eISSN - 1445-5994
pISSN - 1444-0903
DOI - 10.1111/imj.13205
Subject(s) - medicine , malignancy , antibody , intravenous immunoglobulin therapy , retrospective cohort study , immunoglobulin g , intensive care medicine , immunology
Prior randomised studies of immunoglobulin replacement therapy have studied mixed populations with or without a history of infections. Immunoglobulin therapy is expensive and in limited supply suggesting that optimising patient selection is of value. In this retrospective study, infection history identified high‐risk groups benefiting from treatment. A group of patients without any infection history had a low risk of infection without immunoglobulin.